Concurrent Investment Advisors LLC Purchases Shares of 1,422 Universal Health Services, Inc. (NYSE:UHS)

Concurrent Investment Advisors LLC purchased a new position in Universal Health Services, Inc. (NYSE:UHS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,422 shares of the health services provider's stock, valued at approximately $255,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Los Angeles Capital Management LLC increased its stake in shares of Universal Health Services by 102.0% in the third quarter. Los Angeles Capital Management LLC now owns 210,926 shares of the health services provider's stock worth $48,304,000 after acquiring an additional 106,517 shares during the period. AustralianSuper Pty Ltd acquired a new stake in shares of Universal Health Services in the fourth quarter worth $18,709,000. Mizuho Securities USA LLC increased its stake in shares of Universal Health Services by 2,101.2% in the third quarter. Mizuho Securities USA LLC now owns 101,188 shares of the health services provider's stock worth $23,173,000 after acquiring an additional 96,591 shares during the period. World Investment Advisors LLC acquired a new stake in shares of Universal Health Services in the third quarter worth $21,557,000. Finally, Worldquant Millennium Advisors LLC increased its stake in shares of Universal Health Services by 70.8% in the third quarter. Worldquant Millennium Advisors LLC now owns 214,379 shares of the health services provider's stock worth $49,095,000 after acquiring an additional 88,872 shares during the period. Hedge funds and other institutional investors own 86.05% of the company's stock.

Universal Health Services Price Performance

Shares of NYSE:UHS traded down $10.99 during midday trading on Friday, hitting $175.07. The company's stock had a trading volume of 2,056,680 shares, compared to its average volume of 636,538. The business's 50 day simple moving average is $184.47 and its 200 day simple moving average is $205.02. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. The company has a market cap of $11.55 billion, a P/E ratio of 11.64, a price-to-earnings-growth ratio of 0.53 and a beta of 1.30. Universal Health Services, Inc. has a 12-month low of $152.68 and a 12-month high of $243.25.

Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported $4.92 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.71. The firm had revenue of $4.11 billion for the quarter, compared to the consensus estimate of $4.01 billion. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. On average, analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Universal Health Services Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.46%. The ex-dividend date is Monday, March 3rd. Universal Health Services's dividend payout ratio is currently 4.75%.

Insider Transactions at Universal Health Services

In other Universal Health Services news, Director Maria Ruderman Singer sold 1,614 shares of Universal Health Services stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total transaction of $308,516.10. Following the transaction, the director now directly owns 5,879 shares of the company's stock, valued at $1,123,770.85. The trade was a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 16.10% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $226.00 price objective on shares of Universal Health Services in a research note on Tuesday, December 17th. Barclays dropped their price target on shares of Universal Health Services from $271.00 to $249.00 and set an "overweight" rating on the stock in a research report on Thursday. TD Cowen dropped their price target on shares of Universal Health Services from $275.00 to $251.00 and set a "buy" rating on the stock in a research report on Tuesday, November 26th. Stephens raised their price target on shares of Universal Health Services from $210.00 to $223.00 and gave the company an "equal weight" rating in a research report on Friday. Finally, Wells Fargo & Company dropped their price target on shares of Universal Health Services from $285.00 to $230.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Six research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Universal Health Services currently has a consensus rating of "Moderate Buy" and an average price target of $228.77.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.